Applications are call, invited for two or three Clinical PhD Fellowships. Each is financially supported at the appropriate clinical salary on the ST3-7 scale for up to 3.5 years, and provides £45K consumables together with University and College fees, and generous budgets for study and travel. The optional, possible additional 6 months permits fellows either to further develop the proposed clinical project, or to commence, undertake a full 3 years of research before writing up. Successful Fellows can then compete for the post-doctoral Clinical Lectureships in the TMAT programme in order to continue their research and finish specialist clinical training. The Translational Medicine & Therapeutics (TMAT) Clinical Fellowship programme is teamwork between the University of Cambridge, the Wellcome Trust, and GlaxoSmithKline (GSK), designed to train the next generation of leaders in the biologically driven discovery of new medicines.
We are looking for outstanding medical graduates with an enthusiasm and passion for biomedical science and a long-term career intention to combine their clinical and scientific potency in the effort to discover new therapeutics for disorders. Our sole training opportunities arise from the partnership in Cambridge between the fabulous University research environment and superlative facilities for drug-discovery and development within GSK. Fellows will be supervised by a distinguished faculty of University and GSK supervisors in fields including Clinical Pharmacology, Cardiovascular Medicine, Metabolic Medicine, Neurosciences and Mental Health, Oncology, Pharmacological Sciences, and Therapeutic Immunology, in addition to from partner organizations for instance the Wellcome Trust Sanger Institute and the BBSRC Babraham Institute.
The TMAT programme is unique from other clinical PhD programmes. Projects will provide training in some of the expertise required to progress from identification of candidate druggable molecules, through to imaginative proof-of-concept studies in patients. Both basic and clinical research is suitable. At a minimum, outline proposals should comprise a plan for designing, running and/or analyzing one experimental medicine study involving human exposure to drugs. Successful candidates will be expected to engage collaboratively with GSK scientists in the study of drug targets, disease mechanisms, or human pharmacology.
The aim of these TMAT-specific elements of training is to create the new generation of clinical scientists who can translate generously between bench and bedside, and between public and private sectors. The training will not limit the scientific diversity of applications, and certainly first choice will be given to those with an interdisciplinary approach to the problems addressed. A small number of potential projects, already provided by participating Clinical Pharmacology scientists, are accessible for review online at visit.
Applicants might inclination to follow one or more of these listed projects, or to develop their own project, ideas inspiration in collaboration with a potential supervisor. Applicants and their prospective supervisors are recommended to discuss proposals informally with a member of the TMAT faculty (listed above). This consultation is offered to assist candidates identify opportunities for experimental medicine, GSK collaboration, and clinical pharmacology training. Written applications will be short-listed for interview of candidates.
The University of Cambridge has a strong history of graduate training and mentorship. The TMAT programme is based at the Addenbrooke’s Centre for Clinical Investigation (ACCI), in the heart of Addenbrooke’s Hospital. This building was funded by the Medical Research Council, British Heart Foundation, Wellcome Trust and GSK to promote, encourage collaboration among their various clinical research groups in Cambridge. The ACCI provides a central base for the TMAT Fellows and high-tech clinical research facilities. There are many other leading clinical research groups and facilities located nearby on the Cambridge Biomedical Campus, making this an exciting, assorted and helpful clinical research training environment.
Fixed-term: 3 years.
The University values diversity and is committed to equality of opportunity. The University has a responsibility to make certain that all employees are eligible to live and work in the UK. Informal enquiries about the proposal, and requests for administrative guidance on preparation of written applications, can be directed to the programme coordinator, Mrs Katalin Sexton on email@example.com.
Written applications will include a PhD fellowship proposal completed on forms available from the TMAT administrative office and application to the University of Cambridge using the online GRADSAF (Graduate Admission and Scholarship Application Form). You will require making the application to the University of Cambridge by 30th November.
- Further information on how to apply can be found on the link visit:
- Quote reference: RC00660.
12pm on 5th December 2012 with interviews held in January 2013.